WHO ICTRP trial
A study to compare the costs between intravenous Magnesium Sulfate and placebo…
CTRI/2018/04/013309 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2018/04/013309 |
|---|---|
| Public title | A study to compare the costs between intravenous Magnesium Sulfate and placebo in acute exacerbations of chronic obstructive pulmonary disease |
| Scientific title | A PROSPECTIVE STUDY TO COMPARE THE COST EFFECTIVENESS OF I.V. MAGNESIUM SULFATE INFUSION VS. PLACEBO, AS ADJUTANT TO NEBULISED SALBUTAMOL IN ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. |
| Primary sponsor | Kempegowda institute of medical sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: - Health Condition 2: null- acute exacerbations of Chronic obstructive pulmonary disease |
| Interventions | Intervention1: magnesium sulfate infusion: magnesium sulfate infusion 2g in 100ml normal saline over 20-30mins was comapred to placebo as an adjuvant therapy to bronchodilators in acute exacerbations of COPD Control Intervention1: placebo… |
| Registration date | Apr 17, 2018 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: